<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stocks.org &#187; abarnett</title>
	<atom:link href="http://stocks.org/author/abarnett/feed/" rel="self" type="application/rss+xml" />
	<link>http://stocks.org</link>
	<description>Your reliable source for market news and financial insight</description>
	<lastBuildDate>Wed, 16 Mar 2016 20:39:51 +0000</lastBuildDate>
	<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.9.20</generator>
	<item>
		<title>Best Buy’s (NYSE:BBY) Future Market Integration</title>
		<link>http://stocks.org/company/best-buys-nysebby-future-market-integration/29309/</link>
		<comments>http://stocks.org/company/best-buys-nysebby-future-market-integration/29309/#comments</comments>
		<pubDate>Tue, 31 Mar 2015 12:14:15 +0000</pubDate>
		<dc:creator><![CDATA[abarnett]]></dc:creator>
				<category><![CDATA[Company]]></category>
		<category><![CDATA[BBY]]></category>
		<category><![CDATA[best buy]]></category>

		<guid isPermaLink="false">http://stocks.org/?p=9309</guid>
		<description><![CDATA[The company has released a report recently with regards to its stores in Canada. It explained that it is closing down its Canadian branches for the sake of its brand goodwill in the country. Now, the company’s Canadian Future Shop is a chapter of history, with the buyer hardware retailer uniting it under standard of<div class="read-more"><a href="http://stocks.org/company/best-buys-nysebby-future-market-integration/29309/" title="Read More">Read More</a></div><hr style="border-top:black solid 1px" /><a href="http://stocks.org/company/best-buys-nysebby-future-market-integration/29309/">Best Buy’s (NYSE:BBY) Future Market Integration</a> was first posted on March 31, 2015 at 8:14 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></description>
				<content:encoded><![CDATA[
<!-- Easy AdSense V7.22 -->
<!-- [leadin: 2 urCount: 2 urMax: 0] -->
<div class="ezAdsense adsense adsense-leadin" style="float:right;margin:12px;"><script async src="//pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
<!-- Sample one -->
<ins class="adsbygoogle"
     style="display:block"
     data-ad-client="ca-pub-7728471989081824"
     data-ad-slot="6234561790"
     data-ad-format="auto"></ins>
<script>
(adsbygoogle = window.adsbygoogle || []).push({});
</script></div>
<!-- Easy AdSense V7.22 -->
<p>The company has released a report recently with regards to its stores in Canada. It explained that it is closing down its Canadian branches for the sake of its brand goodwill in the country. Now, the company’s Canadian <em>Future Shop</em> is a chapter of history, with the buyer hardware retailer uniting it under standard of Best Buy, a move that unexpectedly disposes of about 1,500 full-time and low maintenance positions all over the country.</p>
<p>Since 2001, the company’s Canadian Future Shop kept on running its 131 stores in unique configuration throughout these years. Presently, 66 of these stores are to be closed down forever, while whatever is left of these outlets will be revived with a designated program. This procedure to single out the two corporations will cost the company around $260 million in rebuilding consumptions.</p>
<p>According to Matt Furman, a representative for Best Buy (NYSEBBY),the company has been proceeding with its operations for about 10 years in the country. The problem is that the business as whole is not growing nor developing in the country. According to him, they are losing the brand equity in the country which is unacceptable.</p>
<p>The experts and analysts also cheered the new move, saying it bodes well for the organization to join the two brands that offer the same sort of items and accessories. In a few places, a portion of the two brands&#8217; outlets were in the same region and at times, so close, that they shared the same parking spots. According to them, this move will benefit the company in the long run.</p>
<p>However, the company will be left with about 192 areas in total with 56 Mobile; and 136 of vast configuration outlets and franchises that in the North of the country. While market spectators complimented the organization&#8217;s new strategy, the same couldn&#8217;t be said in regards to workers being laid off. Moreover, they did not even get any notification ahead of time of the store terminations until that day it was declared openly.</p>
<p>On the other hand, the new move also depicts the most recent episode of turmoil for US retail organizations working in Canada as a whole. Only two months prior to this incident, the retailer Target Corporation (NYSE:TGT) reported its finished shutdown in Canada, which included the closing of all of its 133 outlets, and employment termination of 17,600 workers. The shocking way out from Canada depicted that the corporations messed up by poor store areas, improper estimations, and relentless client dissentions with respect to stock. The company’s turn was soon trailed by Sony Corp&#8217;s. (ADR) (NYSE:SNE), who downsized its operations in the nation too, making it among the string of retail networks that were unable to make their mark in Canada.</p>
<hr style="border-top:black solid 1px" /><a href="http://stocks.org/company/best-buys-nysebby-future-market-integration/29309/">Best Buy’s (NYSE:BBY) Future Market Integration</a> was first posted on March 31, 2015 at 8:14 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></content:encoded>
			<wfw:commentRss>http://stocks.org/company/best-buys-nysebby-future-market-integration/29309/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Apple Inc.’s (NASDAQ:AAPL) Watch May Face Supply and Demand Mismatch</title>
		<link>http://stocks.org/company/apple-inc-s-nasdaqaapl-watch-may-face-supply-and-demand-mismatch/29189/</link>
		<comments>http://stocks.org/company/apple-inc-s-nasdaqaapl-watch-may-face-supply-and-demand-mismatch/29189/#comments</comments>
		<pubDate>Wed, 18 Mar 2015 13:59:47 +0000</pubDate>
		<dc:creator><![CDATA[abarnett]]></dc:creator>
				<category><![CDATA[Company]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Incs]]></category>

		<guid isPermaLink="false">http://stocks.org/?p=9189</guid>
		<description><![CDATA[Tim Arcuri, the analyst at Cowen Group, talked about Apple Inc.’s (NASDAQ:AAPL) stock. According to Mr. Arcuri, Apple Inc. (NASDAQ:AAPL) has done well in coping with the “supply and demand” issue with the iPhone. The supply of iPhones has been going well. However, he predicts that there will be a supply and demand mismatch issue<div class="read-more"><a href="http://stocks.org/company/apple-inc-s-nasdaqaapl-watch-may-face-supply-and-demand-mismatch/29189/" title="Read More">Read More</a></div><hr style="border-top:black solid 1px" /><a href="http://stocks.org/company/apple-inc-s-nasdaqaapl-watch-may-face-supply-and-demand-mismatch/29189/">Apple Inc.’s (NASDAQ:AAPL) Watch May Face Supply and Demand Mismatch</a> was first posted on March 18, 2015 at 9:59 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></description>
				<content:encoded><![CDATA[<p>Tim Arcuri, the analyst at Cowen Group, talked about Apple Inc.’s (NASDAQ:AAPL) stock. According to Mr. Arcuri, Apple Inc. (NASDAQ:AAPL) has done well in coping with the “supply and demand” issue with the iPhone. The supply of iPhones has been going well. However, he predicts that there will be a supply and demand mismatch issue with the Apple Watch as its release date nears.</p>
<p>The iPhone has built up strongly. Mr. Arcuri is of the view that the iPhone maker may even cross the projections for their iPhone units, for the first quarter of the calendar. The company has implied that they may sell more than 50 million iPhones in the CQ1. Mr. Arcuri has made another interesting prediction that in the future Samsung Electronics (KRX:005930), the rival of Apple Inc. (NASDAQ:AAPL), will be a supplier of OLED for iPhones.</p>
<p>About the Apple smart watch, he says that there is a shortage in supply of the wearable. Apple Inc. (NASDAQ:AAPL) is already looking to boost the production of the Apple Watch. For this purpose, the company has collaborated with Foxconn and developed an infrastructure in Japan. Arcuri crunched some numbers and predicted that by June, Apple Inc. (NASDAQ:AAPL) will achieve a rate of 6 million units. Mr. Arcuri believes that the demand of the Apple Watch will be higher than the production rate. He has made another prediction, but this one is regarding the device itself. He believes that there is a possibility that the second edition of the Watch will be released later in the current year. The new version will be able to connect to the internet independently, without the interjection of the iPhone. Mr. Arcuri foresees that the Apple Watch edition 2.0 will be the first device that will incorporate and OLED screen from Samsung Electronics (KRX:005930).</p>
<p>Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE:TSM) is willing to take the production and manufacture of the A9 chips from Apple Inc.’s (NASDAQ:AAPL) hands. This is another speculation by Mr. Tim Arcuri; but it isn’t reported. The Cowen Group has rated Apple Inc.’s (NASDAQ:AAPL) stock at Outperform, which was their previous rating as well. The target price that the firm set on the stock is $115 for each share.</p>
<p>Currently, 58 analysts are covering Apple Inc.’s (NASDAQ:AAPL) stock. Out of these analysts, 15 analysts rate the company’s stock at hold and 41 have rated it at buy. The consensus price target on the company stock is $139.06 on a 12-month basis.</p>
<p>Toni Sacconaghi is an analyst from Sanford C. Bernstein &amp; Co. Apart from Mr. Tim Arcuri, Mr. Sacconhagi’s firm is the only other that rates Apple Inc.’s (NASDAQ:AAPL) stock at outperform. He has given a price target of $135 to the Apple Inc.’s (NASDAQ:AAPL) shares in the next year.</p>
<p>Apple Inc.’s (NASDAQ:AAPL) shares increased by 0.74%. The shares were priced $124.51 during the trading session today in the afternoon. The stock has increased by 10.58% on a year-over-year basis. The iPhone maker may see a supply issue with the Apple Watch but they are well-positioned to handle it.</p>
 <!-- Easy AdSense Unfiltered [count: 3 is not less than 3] --><hr style="border-top:black solid 1px" /><a href="http://stocks.org/company/apple-inc-s-nasdaqaapl-watch-may-face-supply-and-demand-mismatch/29189/">Apple Inc.’s (NASDAQ:AAPL) Watch May Face Supply and Demand Mismatch</a> was first posted on March 18, 2015 at 9:59 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></content:encoded>
			<wfw:commentRss>http://stocks.org/company/apple-inc-s-nasdaqaapl-watch-may-face-supply-and-demand-mismatch/29189/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Some of the Biggest Names Going Down</title>
		<link>http://stocks.org/consumer-staples/some-of-the-biggest-names-going-down/23728/</link>
		<comments>http://stocks.org/consumer-staples/some-of-the-biggest-names-going-down/23728/#comments</comments>
		<pubDate>Tue, 22 Jul 2014 07:13:51 +0000</pubDate>
		<dc:creator><![CDATA[abarnett]]></dc:creator>
				<category><![CDATA[Consumer Staples]]></category>
		<category><![CDATA[AN]]></category>
		<category><![CDATA[EMITF]]></category>
		<category><![CDATA[MAT]]></category>
		<category><![CDATA[YNDX]]></category>
		<category><![CDATA[YUM]]></category>

		<guid isPermaLink="false">http://stocks.org/?p=3728</guid>
		<description><![CDATA[On Thursday, the earnings for AutoNation, Inc. (NYSE:AN), one of the most prominent auto dealers of the U.S. plummeted 6.12%, which was significantly lesser than their calculations. Joseph Amaturo, who is from the Buckingham Research Group, has stated that he was not thrilled and almost disappointed at the outcome of the earnings of AutoNation (NYSE:AN)<div class="read-more"><a href="http://stocks.org/consumer-staples/some-of-the-biggest-names-going-down/23728/" title="Read More">Read More</a></div><hr style="border-top:black solid 1px" /><a href="http://stocks.org/consumer-staples/some-of-the-biggest-names-going-down/23728/">Some of the Biggest Names Going Down</a> was first posted on July 22, 2014 at 3:13 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></description>
				<content:encoded><![CDATA[<p>On Thursday, the earnings for AutoNation, Inc. (NYSE:AN), one of the most prominent auto dealers of the U.S. plummeted 6.12%, which was significantly lesser than their calculations. Joseph Amaturo, who is from the Buckingham Research Group, has stated that he was not thrilled and almost disappointed at the outcome of the earnings of AutoNation (NYSE:AN) and commented on how he thought the company was not widening its share in the new-vehicle market. He also commented on how it was popularly thought and expected that other automakers, for instance General Motors Co. would improve the sales for AutoNation (NYSE:AN), but this proved unfruitful.</p>
<p>Yum! Brands, Inc. (NYSE:YUM) had a 5.88% fall, which came as a bit of a shock for them but was due to its collapse during the second quarter of the year. The descent was recorded to be because of their Pizza Hut restaurants. Yum! Brands, Inc. (NYSE:YUM) has had a significant 19% rise in income, which now equals to $334 million or 73 cents or one share. This is higher than what it was last year, which was $281 million or 61 cents per share. This was what about 22 analysts had predicted; some had even gone to a higher value of 81 cents. The revenue for the company was a gain of 10% to $3.2 billion, which was slightly less than the value they had expected which was $3.24 billion.</p>
<p>Previously, there had been some big announcements related to Elbit Imaging Ltd (NASDAQ:EMITF) regarding their plan also known as the ‘Plan’ for refurbishing their Plaza, the ‘Plan’ has recently been approved by Dutch Court. The Plan was supported and accepted by 92% of the creditors who thought re-doing the Plaza would be a great idea. Elbit Imaging Ltd (NASDAQ:EMITF) is going to have their annual meeting with the shareholders at their company office; the meeting is to be held on Thursday, August 14<sup>th</sup> at 11.00am according to Israel timings and important matters concerning the Company shall be discussed.</p>
<p>In recent times, Elbit Imaging Ltd (NASDAQ:EMITF) has revealed that there shall be an addition to their board of directors and will take over as soon as possible. These new inclusions include David Dekel, Mr. Ron Hadassi, Shlomi Kelsi, Mr. Yaov Kfir and Nadav Livni will accompany the previously appointed members Sarig Shalhav &amp; Messrs Marco Habib Wichers to constitute a board of directors’ team consisting of seven members.</p>
<p>Barbie, once the favorite of all little girls and a fashion icon for many teen girls, is now being faced with some problems. Mattel, Inc. (NASDAQ:MAT), the makers of Barbie, have recently had their sales diminishing a heavy 6.48% due to which, consequently, earnings are depreciating as well. The profits and revenue are less than what was predicted by the market.</p>
<p>The U.S. and European Union now have hard and firm rules set against Russia, and Yandex NV (NASDAQ:YNDX), unfortunately, got sacrificed. The President of the United States, Barack Obama has himself declared these rules concerning Russian banks as well as energy companies due to their strong military support for Ukraine and its separatists.</p>
 <!-- Easy AdSense Unfiltered [count: 3 is not less than 3] --><hr style="border-top:black solid 1px" /><a href="http://stocks.org/consumer-staples/some-of-the-biggest-names-going-down/23728/">Some of the Biggest Names Going Down</a> was first posted on July 22, 2014 at 3:13 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></content:encoded>
			<wfw:commentRss>http://stocks.org/consumer-staples/some-of-the-biggest-names-going-down/23728/feed/</wfw:commentRss>
		<slash:comments>697</slash:comments>
		</item>
		<item>
		<title>Is this the end of Yahoo! Inc. (NASDAQ:YHOO)’s golden era?</title>
		<link>http://stocks.org/consumer-staples/is-this-the-end-of-yahoo-inc-nasdaqyhoos-golden-era/23645/</link>
		<comments>http://stocks.org/consumer-staples/is-this-the-end-of-yahoo-inc-nasdaqyhoos-golden-era/23645/#comments</comments>
		<pubDate>Fri, 18 Jul 2014 07:43:00 +0000</pubDate>
		<dc:creator><![CDATA[abarnett]]></dc:creator>
				<category><![CDATA[Consumer Staples]]></category>
		<category><![CDATA[YHOO]]></category>

		<guid isPermaLink="false">http://stocks.org/?p=3645</guid>
		<description><![CDATA[Since the past year, Yahoo! Inc. (NASDAQ:YHOO) has had its profits deteriorate significantly and this has been a cause of great concern for the company, as commented by Marissa Mayer who is Yahoo! Inc. (NASDAQ:YHOO)’s chief executive officer. Marissa Mayer, as well as the entire Yahoo Team has expressed great agitation over the company’s profit<div class="read-more"><a href="http://stocks.org/consumer-staples/is-this-the-end-of-yahoo-inc-nasdaqyhoos-golden-era/23645/" title="Read More">Read More</a></div><hr style="border-top:black solid 1px" /><a href="http://stocks.org/consumer-staples/is-this-the-end-of-yahoo-inc-nasdaqyhoos-golden-era/23645/">Is this the end of Yahoo! Inc. (NASDAQ:YHOO)’s golden era?</a> was first posted on July 18, 2014 at 3:43 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></description>
				<content:encoded><![CDATA[<p>Since the past year, Yahoo! Inc. (NASDAQ:YHOO) has had its profits deteriorate significantly and this has been a cause of great concern for the company, as commented by Marissa Mayer who is Yahoo! Inc. (NASDAQ:YHOO)’s chief executive officer. Marissa Mayer, as well as the entire Yahoo Team has expressed great agitation over the company’s profit decrease, which has been a 19% decrease since last year, a substantial and prominent difference. The profits now add up to about $270 million.  In the previous quarter, the net profit became quite disappointing and has now dropped even further this time, something no one out of the Yahoo! Inc. (NASDAQ:YHOO) family expected. The company’s revenue has plummeted by 4% as well and is now $1.08 billion.</p>
<p>Marissa Mayer, who joined Yahoo! Inc. (NASDAQ:YHOO) a long time ago, has some plans mapped out for making an attempt to save the struggling company. In one of her talks she illustrated that the strategy devised by Yahoo! Inc. (NASDAQ:YHOO) is to heighten the revenue first and reach targets regarding revenue, something that does not seem to be going as planned. The second quarter has revealed some distressing financial outcomes for them as well. On a slightly positive side, Marissa Mayer declared that a couple of areas can still be ruled out as strengths for the company while others, for instance, display advertising, still need a lot of working on. Mayer was of the view, and rightly so, that the company must act extremely quick and produce some amazing results so as to put the unfavorable tendencies behind them and redeem their old reputation.</p>
<p>Along with Mayer’s statement regarding the financial problems being faced, the CEO of Yahoo! Inc. (NASDAQ:YHOO) has further commented on the situation that the company will take all possible measures to proceed towards something more positive. She seemed quite confident that with a newer approach and better strategies implemented, Yahoo! Inc. (NASDAQ:YHOO) will be able to get back on track fast and the growth of the company shall continue in the future.</p>
<p>In addition to these statements, they have also revealed that Yahoo! Inc. (NASDAQ:YHOO) has arrived on an appropriate agreement with Alibaba, according to which Alibaba shall shed lesser shares than it is supposed to, after its first appearance in the market. This understanding between them has trimmed the share numbers to be sold from 208 million to 140 million, a drastic change in numbers. Ken Goldman, the CFO for Yahoo! Inc. (NASDAQ:YHOO) has declared that revenue resulting from the sale of Yahoo! Inc. (NASDAQ:YHOO)’s stake shall unquestionably be returned to all the shareholders. It is to be noted that Yahoo! Inc. (NASDAQ:YHOO) maintains a stake that accounts for approximately 22% in the Chinese online giant, which has recently disclosed their arrangement for a U.S. IPO.</p>
<p>To comment on the display advertising, a factor that is posing as a major problem for Yahoo! Inc. (NASDAQ:YHOO) at the moment, Yahoo has announced that it has gained sufficient revenue by advertising online and also by advertisement through word searches. This has successfully resulted in cancelling out the degraded revenues which were a consequence of display advertising.</p>
 <!-- Easy AdSense Unfiltered [count: 3 is not less than 3] --><hr style="border-top:black solid 1px" /><a href="http://stocks.org/consumer-staples/is-this-the-end-of-yahoo-inc-nasdaqyhoos-golden-era/23645/">Is this the end of Yahoo! Inc. (NASDAQ:YHOO)’s golden era?</a> was first posted on July 18, 2014 at 3:43 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></content:encoded>
			<wfw:commentRss>http://stocks.org/consumer-staples/is-this-the-end-of-yahoo-inc-nasdaqyhoos-golden-era/23645/feed/</wfw:commentRss>
		<slash:comments>350</slash:comments>
		</item>
		<item>
		<title>JPMorgan Chase &amp; Co. Earnings beat forecasts</title>
		<link>http://stocks.org/consumer-staples/jpmorgan-chase-co-earnings-beat-forecasts/23552/</link>
		<comments>http://stocks.org/consumer-staples/jpmorgan-chase-co-earnings-beat-forecasts/23552/#comments</comments>
		<pubDate>Thu, 17 Jul 2014 05:42:24 +0000</pubDate>
		<dc:creator><![CDATA[abarnett]]></dc:creator>
				<category><![CDATA[Consumer Staples]]></category>
		<category><![CDATA[JPM]]></category>

		<guid isPermaLink="false">http://stocks.org/?p=3552</guid>
		<description><![CDATA[The leading financial services firm, JPMorgan Chase (NYSE: JPM ) reported second quarter earnings of $1.46, better than the analysts’ expectations of $1.29. Nevertheless, the figures declined 9%, falling from $1.60 during the same period last year. Earnings fell to $6 billion vs the $6.5 billion in the same quarter last year.  The company also saw a decline in<div class="read-more"><a href="http://stocks.org/consumer-staples/jpmorgan-chase-co-earnings-beat-forecasts/23552/" title="Read More">Read More</a></div><hr style="border-top:black solid 1px" /><a href="http://stocks.org/consumer-staples/jpmorgan-chase-co-earnings-beat-forecasts/23552/">JPMorgan Chase &#038; Co. Earnings beat forecasts</a> was first posted on July 17, 2014 at 1:42 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></description>
				<content:encoded><![CDATA[<p>The leading financial services firm, <strong>JPMorgan Chase</strong> (NYSE: <a href="http://caps.fool.com/Ticker/JPM.aspx?source=isssitthv0000001">JPM</a><a href="http://my.fool.com/watchlist/add?ticker=JPM&amp;source=iwlsitbut0000010"> </a>) reported second quarter earnings of $1.46, better than the analysts’ expectations of $1.29. Nevertheless, the figures declined 9%, falling from $1.60 during the same period last year.</p>
<p>Earnings fell to $6 billion vs the $6.5 billion in the same quarter last year.  The company also saw a decline in revenue which fell to $1.3 billion from the previous numbers of $1.8 billion.</p>
<p>Moreover, net income of the Corporate and Investment Bank at JP Morgan also posted a decline of 31% from a year earlier to value $2 billion. Revenue at the bank market also slipped 23% from the previous year to $2.9 billion. It was hurt by a drop in trading revenue which includes commodity contracts, debt and equity revenue.</p>
<p>The bank however did note that it identified the legal expenses as a cause in the reduction of EPS by $0.13 as well as the $500 million drop in net income in the second quarter.</p>
<p>JP Morgan Chase saw some encouraging signs of a pickup in some of its businesses including Commercial Banking and Asset Management, wherein the net income rose by 6% and 10% respectively, to a combined total of $1.2 billion.</p>
<p>CEO Jamie Dimon, JPMorgan Chase stated in the company’s earnings announcement that the firm managed to deliver a strong performance even in the face of persistent headwinds in Market and Mortgage finance. He also mentioned that the deposit growth of card sales numbers and Consumer &amp; Community Banking had improved much faster than the rest of the industry, including record making loan originations in the company’s Business Banking.</p>
<p>Overall, the total return on assets valued 0.99% and as far as tangible common equity returns are concerned, the figures stood at 14%. The numbers saw an improvement from this year’s first quarter, even though these were below figures reported in 2013 second quarter.</p>
<p>The return on assets during the winter quarter last year stood at 1.09%, greater than the ROA figures of the second quarter 2014 which currently value 0.99. On the other hand, the return on assets during the present year’s first quarter was 0.89.</p>
<p>Similarly Return on Tangible Common Equity during the second quarter of 2014 saw an increase from the numbers posted in the present year’s first quarter. The figures rose from 13% to 14%. However, both of these values were below the return on tangible common equity reported in the winter quarter last year which stood at 17%.</p>
<p>Dimon concluded his speech saying that JPMorgan Chase and Bank had been able to achieve extraordinary milestones by overcoming remarkable challenges during this quarter which also celebrated the tenth anniversary of JPMorgan Chase and Bank. He also contributed that the firm will continue to progress by adapting to the new worldwide financial architecture and make advancements to their control agenda. In the end he remarked that he had much greater pride in the company now.</p>
 <!-- Easy AdSense Unfiltered [count: 3 is not less than 3] --><hr style="border-top:black solid 1px" /><a href="http://stocks.org/consumer-staples/jpmorgan-chase-co-earnings-beat-forecasts/23552/">JPMorgan Chase &#038; Co. Earnings beat forecasts</a> was first posted on July 17, 2014 at 1:42 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></content:encoded>
			<wfw:commentRss>http://stocks.org/consumer-staples/jpmorgan-chase-co-earnings-beat-forecasts/23552/feed/</wfw:commentRss>
		<slash:comments>552</slash:comments>
		</item>
		<item>
		<title>Soaring Volume in Biotech: Lexicon Pharmaceuticals (NASDAQ:LXRX), Bluebird bio Inc (NASDAQ:BLUE), BioDelivery Sciences International, Inc. (NASDAQ:BDSI, Acasti Pharma (NASDAQ:ACST), Ultragenyx Pharmaceutical (NASDAQ:RARE)</title>
		<link>http://stocks.org/biopharma/soaring-volume-in-biotech-lexicon-pharmaceuticals-nasdaqlxrx-bluebird-bio-inc-nasdaqblue-biodelivery-sciences-international-inc-nasdaqbdsi-acasti-pharma-nasdaqacst-ultragenyx-pharmac/23362/</link>
		<comments>http://stocks.org/biopharma/soaring-volume-in-biotech-lexicon-pharmaceuticals-nasdaqlxrx-bluebird-bio-inc-nasdaqblue-biodelivery-sciences-international-inc-nasdaqbdsi-acasti-pharma-nasdaqacst-ultragenyx-pharmac/23362/#comments</comments>
		<pubDate>Sat, 12 Jul 2014 07:42:28 +0000</pubDate>
		<dc:creator><![CDATA[abarnett]]></dc:creator>
				<category><![CDATA[BioPharma]]></category>
		<category><![CDATA[ACST]]></category>
		<category><![CDATA[BLUE]]></category>
		<category><![CDATA[LXRX]]></category>
		<category><![CDATA[rare]]></category>

		<guid isPermaLink="false">http://stocks.org/?p=3362</guid>
		<description><![CDATA[According to the news, JDRF, the biggest non-profit supporter of research firms that conduct experiments on type 1 diabetes’ drugs, has agreed to provide funding to Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) for its phase II trials on the safety and efficacy of LX4211 drug. In its phase II testing, LX4211 will be used on younger individuals;<div class="read-more"><a href="http://stocks.org/biopharma/soaring-volume-in-biotech-lexicon-pharmaceuticals-nasdaqlxrx-bluebird-bio-inc-nasdaqblue-biodelivery-sciences-international-inc-nasdaqbdsi-acasti-pharma-nasdaqacst-ultragenyx-pharmac/23362/" title="Read More">Read More</a></div><hr style="border-top:black solid 1px" /><a href="http://stocks.org/biopharma/soaring-volume-in-biotech-lexicon-pharmaceuticals-nasdaqlxrx-bluebird-bio-inc-nasdaqblue-biodelivery-sciences-international-inc-nasdaqbdsi-acasti-pharma-nasdaqacst-ultragenyx-pharmac/23362/">Soaring Volume in Biotech: Lexicon Pharmaceuticals (NASDAQ:LXRX), Bluebird bio Inc (NASDAQ:BLUE), BioDelivery Sciences International, Inc. (NASDAQ:BDSI, Acasti Pharma (NASDAQ:ACST), Ultragenyx Pharmaceutical (NASDAQ:RARE)</a> was first posted on July 12, 2014 at 3:42 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></description>
				<content:encoded><![CDATA[<p>According to the news, JDRF, the biggest non-profit supporter of research firms that conduct experiments on type 1 diabetes’ drugs, has agreed to provide funding to Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) for its phase II trials on the safety and efficacy of LX4211 drug. In its phase II testing, LX4211 will be used on younger individuals; it will be administered to around 76 individuals, with type 1 diabetes, under the age of 30 years. For a period of 12 weeks, these individuals will be given either a placebo or a daily dose of 400mg of LX4211.</p>
<p>Talking about the stocks of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), in the last trading session, these closed at a price of $1.56. As far as company’s institutional and insider ownership is concerned, the figures are reported to be around 85.90% and 0.40% respectively. Moreover, the company’s total outstanding shares reached the figures of 514.94 million shares.</p>
<p>Coming to the share prices of Bluebird bio Inc (NASDAQ:BLUE), the company, on the last trade day, saw a decrease of 1.18 percent and closed its shares at a price of $33.94. The company has a 52 week high of $35.55 and a 52 week low of $33.55. Moreover, it has a market capitalization of $831.94 billion whereas 24.51 million company’s shares are recorded to be outstanding shares.</p>
<p>BioDelivery Sciences International, Inc. (NASDAQ:BDSI) stocks saw an increase when the company announced positive results for its phase III study; the company was running efficacy tests for its pain killer, BEMA buprenorphine.</p>
<p>In last trading session, total trading volume of BioDelivery Sciences International, Inc. (NASDAQ:BDSI)’s stocks reached 2.28 million shares, much greater than its average volume of 1.28 million shares. Moreover, the stocks started at $675.29 and closed at $13.94.</p>
<p>Coming to Acasti Pharma Inc (NASDAQ:ACST), the company’s stocks jumped up following the news of its successful trials. The company focuses on development of drugs used in the prevention and treatment of cardio metabolic disorders. The company has completed its Phase I and Phase II of the trials, and rumors have it that it will be successful in getting FDA approval for the execution of Phase III in the United States.</p>
<p>Talking about Acasti Pharma Inc (NASDAQ:ACST)’s stock prices, in the last trading session, the company’s stocks started at a price of $1.10 and ended at a price of $1.08. The highest figures hit by the stocks were recorded to be $1.22, with a weekly performance of -6.78 percent.</p>
<p>Lastly, Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) disclosed that the company is offering around 2,017,349 shares to the public. According to the company, the shares belong to the common stock rank and the selling price will be $40 per share.</p>
<p>In last trade session, the shares of Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) started at a price of $40.50 and closed at a price of $40.00. The intra-day range for company’s stocks was recorded to be $37.77 to $40.99 whereas the total market capitalization of the company reached the figures of $1.20 billion.</p>
 <!-- Easy AdSense Unfiltered [count: 3 is not less than 3] --><hr style="border-top:black solid 1px" /><a href="http://stocks.org/biopharma/soaring-volume-in-biotech-lexicon-pharmaceuticals-nasdaqlxrx-bluebird-bio-inc-nasdaqblue-biodelivery-sciences-international-inc-nasdaqbdsi-acasti-pharma-nasdaqacst-ultragenyx-pharmac/23362/">Soaring Volume in Biotech: Lexicon Pharmaceuticals (NASDAQ:LXRX), Bluebird bio Inc (NASDAQ:BLUE), BioDelivery Sciences International, Inc. (NASDAQ:BDSI, Acasti Pharma (NASDAQ:ACST), Ultragenyx Pharmaceutical (NASDAQ:RARE)</a> was first posted on July 12, 2014 at 3:42 am.<br />©2014 "<a href="http://stocks.org">Stocks.org</a>". Use of this feed is for personal non-commercial use only. If you are not reading this article in your feed reader, then the site is guilty of copyright infringement. Please contact me at hso@stocks.org<br />]]></content:encoded>
			<wfw:commentRss>http://stocks.org/biopharma/soaring-volume-in-biotech-lexicon-pharmaceuticals-nasdaqlxrx-bluebird-bio-inc-nasdaqblue-biodelivery-sciences-international-inc-nasdaqbdsi-acasti-pharma-nasdaqacst-ultragenyx-pharmac/23362/feed/</wfw:commentRss>
		<slash:comments>239</slash:comments>
		</item>
	</channel>
</rss>
